Log in
Advanced Prostate Cancer
6,005 members5,761 posts

Top doc's top story - STAMPEDE

Here's a note from Alan W. Partin, MD, PhD, Chief Urologist and Director of the Department of Urology at Johns Hopkins. He's a famous research scientist known for the Partin Tables among other things. He thinks the STAMPEDE trial that showed the superiority of ADT (e.g., Lupron) + abiraterone (Zytiga) over ADT alone is the top story in prostate cancer for 2017.

practiceupdate.com/expertop...

Alan

12 Replies
oldestnewest

Since I am on this protocol, I obviously agree with the doctor.

Rich

5 likes
Reply

Amen! me too

Reply

Thank you Alan

Reply

Considering how many of us are now on Lupron and Zytiga I would agree.

Reply

Thanks a lot Alan.

Sisira

Reply

Trying to get Zytiga added. Wish me luck.

Doug

Reply

Good luck!

Maybe showing your doc the note from (TA-DAAA) Alan Partin will help convince him.

Alan

Reply

Darned PSA went up, now above 0.2, but made it easy to get Xtandi added to treatments..now wait and see what it does....

Doug

Reply

I am lucky . That is my treatment hoping and praying. Wishing everyone good health.

Reply

It is also my initial treatment I’m very thankful for the ability to have this drug at diagnosis. 👍

Reply

I started this as a clinical trial about 7 months ago along with a test medication (apalutimide). So far my PSA dropped from 18 to 0.6, my lymph nodes shrunk to normal size and no cancer cells identified in blood stream. I hope this works for a while!

1 like
Reply

you are blessed. grazie Dio. Tante buone cose.

Reply

You may also like...